The Navy’s development of wearable light technology has led to the creation of LifeWave, a company offering products that claim to enhance cellular health. According to reports, David Schmidt, founder of Advanced Applications Group, was tasked with designing a device for sailors to improve their performance, resulting in a product later commercialized by LifeWave.
The X39 patch, LifeWave’s flagship item, is marketed as a wearable light technology that activates the body’s natural production of copper peptides, potentially stimulating stem cell activity. Proponents suggest it may address age-related decline, including joint discomfort and skin texture. Testimonials describe relief from conditions such as lower back pain and chest discomfort, though these claims lack peer-reviewed scientific validation.
The product is also promoted as an alternative to costly medical procedures like stem cell injections, which can cost up to $50,000 per treatment. Some users report benefits after short-term use, including improved mobility and reduced inflammation. Additional LifeWave products, such as the Aeon patch for relaxation and IceWave for pain relief, are highlighted as complementary solutions.
The article includes anecdotes from individuals who claim personal health improvements, though no independent evidence is provided to support these assertions. The text emphasizes affordability compared to traditional medical treatments but avoids addressing regulatory scrutiny or clinical trials.
Promotional language underscores the product’s potential to “reverse aging” and “alleviate discomfort,” with users encouraged to explore its benefits through direct purchase.